The Raf–MEK1/2–ERK1/2 module is activated by growth factors and proteins overexpressed in human breast cancer epithelium, by cytokines and hormones produced by fibroblasts and macrophages in the mammary stromal compartment, and by increased tissue stiffness observed during tumor progression [10,12]. The gene discussed is MAPK3; the disease is breast carcinoma.